The impact of sleep disorders in the development of hypertension

被引:2
作者
Isayeva, Ganna [1 ]
Shalimova, Anna [1 ,2 ]
Buriakovska, Olena [1 ,3 ]
机构
[1] Natl Acad Med Sci Ukraine, Govt Inst, LT Malaya Therapy Natl Inst, Kharkiv, Ukraine
[2] Kharkiv Natl Med Univ, Kharkiv, Ukraine
[3] Natl Acad Med Sci Ukraine, Dept Chron Noncommunicable Dis Prevent, Govt Inst, LT Malaya Therapy Natl Inst, Kharkiv, Ukraine
来源
ARTERIAL HYPERTENSION | 2022年 / 26卷 / 04期
关键词
hypertension; insomnia; sleep disorders; SERUM PROLACTIN CONCENTRATIONS; RESTLESS LEGS SYNDROME; SLOW-WAVE SLEEP; BLOOD-PRESSURE; INSUFFICIENT SLEEP; SALIVARY CORTISOL; CHRONIC INSOMNIA; CIRCADIAN RHYTHMICITY; INCIDENT HYPERTENSION; METABOLIC SYNDROME;
D O I
10.5603/AH.a2022.0014
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertension is one of the most common chronic non-communicable diseases in the world. Risk factors, methods of prevention and treatment of hypertension have been sufficiently studied. However scientists are still looking for pathogenetic mechanisms of its development. At the same time, 36.9% of patients with hypertension had different sleep disorders. Patients with insomnia have a 21% higher risk of developing hypertension compared with those who have quality sleep. Hypnotics are given up to 15% of patients with hypertension. Hypnotics have been shown to increase the risk of cardiovascular events. As much as 44.1% of patients with established diseases of the cardiovas-cular system have problems with the quality or duration of sleep. At this time, hypertension and sleep disorders are considered mutually aggravating diseases.Key words: hypertension; sleep disorders; insomnia
引用
收藏
页码:170 / 179
页数:10
相关论文
共 91 条
  • [41] Serotonin regulates pancreatic beta cell mass during pregnancy
    Kim, Hail
    Toyofuku, Yukiko
    Lynn, Francis C.
    Chak, Eric
    Uchida, Toyoyoshi
    Mizukami, Hiroki
    Fujitani, Yoshio
    Kawamori, Ryuzo
    Miyatsuka, Takeshi
    Kosaka, Yasuhiro
    Yang, Katherine
    Honig, Gerard
    van der Hart, Marieke
    Kishimoto, Nina
    Wang, Juehu
    Yagihashi, Soroku
    Tecott, Laurence H.
    Watada, Hirotaka
    German, Michael S.
    [J]. NATURE MEDICINE, 2010, 16 (07) : 804 - U106
  • [42] Kirschbaum C., 2000, Encyclopedia of Stress, P424, DOI DOI 10.1159/000118611
  • [43] Association Between Sleep and Blood Pressure in Midlife The CARDIA Sleep Study
    Knutson, Kristen L.
    Van Cauter, Eve
    Rathouz, Paul J.
    Yan, Lijing L.
    Hulley, Stephen B.
    Liu, Kiang
    Lauderdale, Diane S.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (11) : 1055 - 1061
  • [44] Self-reported sleep duration in Finnish general population
    Kronholm, Erkki
    Harma, Mikko
    Hublin, Christer
    Aro, Arja R.
    Partonen, Timo
    [J]. JOURNAL OF SLEEP RESEARCH, 2006, 15 (03) : 276 - 290
  • [45] Sleep Duration in the United States: A Cross-sectional Population-based Study
    Krueger, Patrick M.
    Friedman, Elliot M.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 (09) : 1052 - 1063
  • [46] A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters
    Lamos, E. M.
    Levitt, D. L.
    Munir, K. M.
    [J]. PRIMARY CARE DIABETES, 2016, 10 (01) : 60 - 65
  • [47] Nighttime Blood Pressure in Normotensive Subjects With Chronic Insomnia: Implications for Cardiovascular Risk
    Lanfranchi, Paola A.
    Pennestri, Marie-Helene
    Fradette, Lorraine
    Dumont, Marie
    Morin, Charles M.
    Montplaisir, Jacques
    [J]. SLEEP, 2009, 32 (06) : 760 - 766
  • [48] EFFECTS OF SPECIFIC ACTIVATION OF MU-OPIOID, DELTA-OPIOID AND KAPPA-OPIOID RECEPTORS ON THE SECRETION OF LUTEINIZING-HORMONE AND PROLACTIN IN THE OVARIECTOMIZED RAT
    LEADEM, CA
    YAGENOVA, SV
    [J]. NEUROENDOCRINOLOGY, 1987, 45 (02) : 109 - 117
  • [49] Léger D, 2001, REV NEUROL-FRANCE, V157, P1270
  • [50] Sleep and hypertension - A challenge for the autonomic regulation of the cardiovascular system
    Legramante, JM
    Galante, A
    [J]. CIRCULATION, 2005, 112 (06) : 786 - 788